Zeltiq Shines Spotlight on CoolAdvantage Petite Applicator at AAD Annual Meeting

Saturday, March 04, 2017 | Personnel/Company News , Lasers & Light Devices , Zeltiq


ZELTIQ® Aesthetics is showcasing the CoolAdvantage Petite™ applicator at the American Academy of Dermatology Annual Meeting (AAD) in Orlando.  The CoolAdvantage technology is the only non-invasive fat removal technology cleared by the Food and Drug Administration (FDA) to address the upper arm.

“After 5 years of research and millions of dollars invested in development, we are proud to be the only non-invasive fat reduction technology that is FDA-cleared to treat the upper arms, the third greatest area of concern for consumers,” said Mark Foley, President and Chief Executive Officer of ZELTIQ.  “Through direct-to-consumer advertising, we plan to raise awareness around this new treatment area and help drive consumers to our customers’ CoolSculpting practices.”

The newest member of the CoolAdvantage family of applicators, the CoolAdvantage Petite treats the upper arm in just 35 minutes and comes with two interchangeable contours customized to treat the unique shape of the upper arm area.  The commercial release of the CoolAdvantage Petite applicator is planned for the middle part of 2017.

“The upper arm, with its delicate structures, is one of the most challenging areas for fat reduction,” said Jean Carruthers, MD, FRCSC, FRC(OPHTH), of Carruthers & Humphrey Cosmetic Dermatology in Vancouver, Canada.  “As one of the principal investigators for the CoolAdvantage Petite applicator, I can attest to the fact that the upper arms responded beautifully and my study patients are delighted by their results.”

Providers attending AAD who want to learn more about the CoolSculpting procedure and CoolAdvantage Petite applicator can visit CoolSculpting Booth #1231 in the Orange County Convention Center during exhibit hours 10 a.m. to 5 p.m. March 3-4, and 10 a.m. to 3 p.m. on March 5.  You can also learn more by visiting www.coolsculptinghcp.com.

 

Next Story

Comments

You must be logged in to leave a comment.